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ORIGINAL ARTICLE
Probiotic Lactobacillus reuteri has antifungal effects on oral Candida species in
vitro
Mette Rose Jørgensena, Camilla Kragelunda, Peter Østrup Jensenb, Mette Kirstine Kellera
and Svante Twetmana
aDepartment of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; bDepartment of
Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
ABSTRACT
Background: An alternative approach for managing Candida infections in the oral cavity by
modulating the oral microbiota with probiotic bacteria has been proposed.
Objective: The aim was to investigate the antifungal potential of the probiotic bacterium
Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) against six oral Candida species (C.
albicans, C. glabrata, C. krusei, C. tropicalis, C. dubliniensis, and C. parapsilosis).
Design: The lactobacilli were tested for their ability to co-aggregate with and inhibit the
growth of the yeasts assessed by spectrophotometry and the agar overlay inhibition assay.
Additionally, the pH was evaluated with microsensors, and the production of hydrogen
peroxide (H2O2) by the lactobacilli was verified.
Results: Both L. reuteri strains showed co-aggregation abilities with the yeasts. The lactoba-
cilli almost completely inhibited the growth of C. albicans and C. parapsilosis, but did not
affect C. krusei. Statistically significant differences in co-aggregation and growth inhibition
capacities between the two L. reuteri strains were observed (p<0.001). The pH measurements
suggested that C. krusei can resist the acids produced by the lactobacilli.
Conclusions: L. reuteri exhibited antifungal properties against five of the six most common
oral Candida species. Further, the results reconfirms that the probiotic capacity of L. reuteri is
strain specific.
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Candida species are commensals in the oral cavity
and part of the normal microbiota in 25–75% of
healthy individuals [1]. Nevertheless, Candida species
are opportunistic pathogens which under certain cir-
cumstances cause infections in the oral mucosa,
termed oral candidiasis. Infections are primarily
caused by Candida albicans that has the ability to
switch between the blastospore form and the more
invasive hyphae form. Other Candida species have
been isolated from infected sites in the oral cavity,
including C. glabrata, C. krusei, C. tropicalis, C. dubli-
niensis, and C. parapsilosis [2,3]. Currently, an
increase in fungal resistance to antimycotic therapy
causes concern, and as a consequence an alternative
bio-ecological approach of fungal management has
been proposed [4].
There is a growing interest in probiotic bacteria to
prevent and combat oral diseases [5]. Probiotic bac-
teria are defined by the World Health Organization as
‘Live microorganisms that, when administered in
adequate amounts, confer a health benefit on the
host’ [6]. The most common probiotic genera
Bifidobacterium and Lactobacillus are believed to act
by competitive exclusion of pathogens from the oral
mucosal adhesion sites, by competing for available
nutrients, and by altering the mucosal immune host
defence [7,8]. In addition, some probiotic bacteria
produce acids from carbohydrate fermentation ren-
dering a low pH, and some lactic acid bacteria pro-
duce hydrogen peroxide (H2O2) and bacteriocins
which are harmful to pathogens [5]. The probiotic
Lactobacillus reuteri has been shown to survive the
passage through the ventricle and to colonize the
human gastrointestinal tract transiently [9]. Under
certain favourable conditions, L. reuteri produces a
broad-spectrum antimicrobial substance, reuterin,
assumed to inhibit DNA synthesis in pathogens in
the surrounding environment [10]. In a randomized
placebo-controlled clinical trial, the authors’ research
group has recently reported a significant reduction of
the oral Candida load in a group of frail elderly
persons after probiotic intervention with L. reuteri
DSM 17938 and ATCC PTA 5289 in a combined
lozenge [11].
The ability of lactobacilli to co-aggregate with
pathogens such as Candida is central in biofilm for-
mation and is a desired feature of probiotics.
Through co-aggregation, the lactobacilli may achieve
an adequate mass and thereby have the ability to
create a hostile micro-environment around the
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Candida species with high concentrations of sub-
stances such as acids, H2O2, bacteriocins, and so on
that possibly inhibit the pathogens’ growth [12]. In
vitro studies have investigated co-aggregation and
growth inhibition of probiotic and pathogenic bac-
teria [12–14], with the focus being on caries- and
periodontitis-associated microorganisms [13–15].
For C. albicans, probiotic interference has been
demonstrated with probiotic lactobacilli, for example
L. rhamnosus GR-1, L. reuteri RC-14, and L. reuteri
ATCC PTA 5289 [16–18]. To the authors’ knowledge,
only a few studies have looked into the antifungal
effect of probiotic lactobacilli on non-albicans
Candida species commonly found in the oral cavity
[19–21]. The aim of this study was therefore to
investigate the in vitro abilities of two strains of the
probiotic L. reuteri, with demonstrated ability to
reduce the Candida load in vivo in a vulnerable
population and to co-aggregate with and inhibit the
growth of six opportunistic pathogenic oral Candida
species. Additionally, the pH, as an expression of acid
production by the lactobacilli, was evaluated through
agar plates with Candida-Lactobacillus co-cultures.
Moreover, the ability of the lactobacilli to produce
H2O2 was verified.
Materials and methods
Strains and culture conditions
Two strains of the probiotic L. reuteri (DSM 17938
and ATCC PTA 5289; Biogaia, Stockholm, Sweden)
were used in this study. The Candida strains used
were six laboratory reference strains from the Culture
Collection, University of Gothenburg, Sweden: C.
albicans CCUG 46390; C. dubliniensis CCUG 48722;
C. glabrata CCUG 63819; C. krusei CCUG 56126; C.
parapsilosis CCUG 56136, and C. tropicalis CCUG
47037. In addition, six clinically isolated strains
from humans were included, generously provided
by the Department of Clinical Microbiology,
Rigshospitalet, Copenhagen, Denmark. Prior to the
in vitro studies, the clinical strains were characterized
by matrix-assisted laser desorption/ionization time-
of-flight (MALDI-TOF) mass spectrometry [22] to
confirm their identity as C. albicans CBS 562 NT, C.
dubliniensis 41_3 ZZMK, C. glabrata CBS 863, C.
krusei (Issatchenkia orientalis RV 491), C. parapsilosis
26 PBS, and C. tropicalis DSM 7524.
The lactobacilli were initially cultured on de Man
Rogosa Sharpe (MRS) agar (Oxoid Ltd., Basingstoke,
Hampshire, UK) for 24 h in an anaerobic chamber at
37°C (10% H2, 5% CO2, and 85% N2). The Candida
strains were cultured on BD Difco™ Sabouraud
Maltose (DSM) agar (Becton, Dickinson and
Company, Sparks, MD) for 24 h in ambient air at
37°C.
Co-aggregation assay
The co-aggregation was determined spectrophotome-
trically (Genesys™ 10S UV-Vis Spectrophotometer;
Thermo Fisher Scientific, Waltham, MA) and exe-
cuted as described previously by Collado et al. [12].
In brief, one distinct colony of overnight cultured
lactobacilli was transferred to 5 mL MRS broth and
incubated at 37°C for 24 h under anaerobic condi-
tions. The Candida strains were similarly harvested
and aerobically incubated in DSM broth at 37°C for
24 h. After incubation, the lactobacilli and Candida
were harvested by centrifugation at 855 g (Sigma 2-6
Compact Centrifuge, Sigma, Poole, UK) for 10 min at
room temperature, washed three times in phosphate-
buffered saline (PBS), and resuspended in neutral
10 mmol/L PBS (pH 7.0). The absorbance was
adjusted to an optical density (OD) of 0.5 at
600 nm (approximately 108 cfu/mL of the lactobacilli)
by using the spectrophotometer to ensure identical
densities at baseline. Equal volumes (1.0 mL) of the
lactobacilli and Candida strains were mixed and incu-
bated aerobically at 37°C for 1, 2, and 4 h without
agitation, but were vortexed prior to each OD mea-
surement. Co-aggregation was calculated by using the
equation [12,15]:
% coaggregation ¼ OD0  ODh
OD0
 100
where OD0 is the absorbance of the mixed suspen-
sion at baseline (0 h) and ODh is the absorbance of
the mixed solutions at different time points (1, 2, and
4 h). The assays were carried out in duplicate and
repeated four times on different occasions.
Agar overlay interference test
The growth inhibition assay was performed as
described earlier [14,23]. In brief, one distinct colony
of overnight cultured lactobacilli was transferred to
5 mL MRS broth and incubated at 37°C for 24 h
under anaerobic conditions. The following day, the
lactobacilli were harvested by centrifugation at 855 g
for 10 min at room temperature. The supernatants of
the two Lactobacillus strains were obtained after cen-
trifugation and filter sterilized by the aid of sterile
20 mL syringes (Omnifix®; B. Braun, Melsungen,
Germany) and syringe filters, 0.8/0.2 µm pore size
membranes (Acrodisc® PF Syringe Filter; Pall Life
Sciences, Lund, Sweden). The pellets were washed
three times in PBS and resuspended in MRS broth.
The OD was adjusted spectrophotometrically to 1.8 at
630 nm (corresponding to approximately 109 cfu/
mL). The cultures were then serially diluted in MRS
broth in 10-fold steps. One millilitre of the super-
natants, undiluted suspensions, and cell suspensions
corresponding to approximately 107, 105, and 103
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CFU/mL were added to 24 m sterilized molten MRS
agar (~45°C) in Petri dishes, and the agar was allowed
to solidify. The plates were incubated overnight at 37°
C under anaerobic conditions.
One single colony of each of the overnight cul-
tured Candida strains was added to 5 mL DSM broth
and aerobically incubated at 37°C for 24 h. The
following day, one additional layer of 25 mL of mol-
ten sterile DSM agar was poured on top of the MRS
agar with grown lactobacilli and supernatants, and
was allowed to solidify and air-dry for 3 h at room
temperature. The overnight-cultured Candida strains
were diluted in DSM broth to a final OD of 0.2 at
500 nm. The Candida suspensions were stamped on
the plates with a Steers steel-pin replicator (CMI-
Promex ICN, Pedricktown, NJ) and left to dry for
1 h at room temperature. The plates were subse-
quently aerobically incubated overnight at 37°C. As
controls, the Candida strains were also stamped on
top of plates with no lactobacilli within the bottom
MRS agar layer.
The assays were carried out in duplicate and
repeated four times on different occasions. The
results were evaluated in accordance with Simark-
Mattson et al. [23] as follows: a score of 0 = complete
inhibition (no visible colonies); a score of 1 = slight
inhibition (at least one visible colony but definitely
smaller amounts than at control plate); and a score of
2 = no inhibition (colonies equal to those at the
control plate). Two observers scored the plates inde-
pendently, and in case of disagreement, consensus
was reached through discussion.
Microsensor measurements of pH
To estimate the acid production of the lactobacilli
and the effect of pH on Candida growth, pH was
measured with a pH microelectrode (pH-25;
Unisense A/S, Århus, Denmark) using a modifica-
tion of a previously described procedure [24] in
selected plates from the abovementioned agar over-
lay interference test. A reference electrode was used
to establish a reference potential against the pH
microelectrode (ref-100, Unisense A/S). The elec-
trodes were mounted in a motorized PC-controlled
profiling setup (MM33 and MC-232, Unisense A/S).
Positioning and data acquisition were controlled by
dedicated software (Sensortrace Pro 2.0, Unisense
A/S). The pH and reference electrodes were cali-
brated with buffers of pH 4 and 7 at room tem-
perature. The pH microelectrode had a detection
limit of 0.1 pH units. The pH was measured on
the final day of the agar overlay interference test
after scoring the plates. Selection of the plates was
based on the results from the interference test: pH
was measured through dense, non-inhibited colo-
nies of Candida (C. krusei CCUG 56126 and C.
tropicalis CCUG 47037) and through vague, almost
completely inhibited colonies (C. albicans CCUG
46390 and C. glabrata CCUG 63819) incubated on
plates with L. reuteri DSM 17938 and ATCC PTA
5289 (103 CFU/mL), respectively. In addition, pH
was measured in control plates containing only the
lactobacilli in the bottom agar layer, but with no
Candida incubated, and in a control plate with
Candida strains but without lactobacilli. Finally,
pH was measured at a control agar plate without
lactobacilli or Candida strains. Before commencing
the measurements, the pH and reference electrodes
were placed approximately 2 mm above the surface
of the Candida colonies. The electrodes were set to
move in steps of 100 µm, and pH was measured
from the surface of the colonies and then for every
100 µm until the depth of 4.5 mm into the agar to
make sure the sensors had reached the bottom agar
layer containing the lactobacilli. The experiment
was repeated twice at two different occasions.
H2O2 production by the lactobacilli
In order to verify the ability of the two L. reuteri
strains to produce H2O2, a method described by
Kang et al. [25] was used. Briefly, one single colony
of overnight cultured L. reuteri strains was plated
onto MRS agar containing 0.25 mg/mL 3,3',5,5'-tetra-
methylbenzidine (Sigma, Poole, UK) and 0.01 mg/mL
peroxidase from horseradish (Sigma) and incubated
anaerobically for 48 h at 37°C. As controls, two
bacterial strains known to produce H2O2
(Streptococcus sanguinis and S. mitis) and one strain
known not to produce H2O2 (S. salivarius) [26] were
grown on similar plates incubated under the same
conditions. After incubation, the plates were exposed
to ambient air, and colonies displaying a surrounding
blue halo were considered to produce H2O2.
Statistical analysis
Statistical analyses were processed with SAS Enterprise
guide software v7.1 (SAS Institute, Inc., Cary, NC). A
p-value of <0.05 was considered statistically significant.
Data analysis on co-aggregation was subjected to one-
way analysis of variance and Tukey’s post-hoc analysis,
and presented as mean and standard deviations (SD).
Data obtained from the agar overlay interference test
were analysed by the chi-square test and presented as
the median inhibition score.
Results
Co-aggregation between lactobacilli and yeasts
L. reuteri ATCC PTA 5289 and L. reuteri DSM 17938
showed the ability to co-aggregate with both clinical
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and reference Candida strains. Co-aggregation
increased significantly over time (1, 2, and 4 h) for
all combinations of Candida and probiotic strains
(p <0.05). For all the tested Candida strains, L. reuteri
PTA 5289 showed a statistically significantly higher
co-aggregation ratio than L. reuteri DSM 17938 after
4 h incubation (p <0.001). The results of the co-
aggregation ratios (%) after 4 h are presented in
Figure 1.
Growth inhibition of Candida by L. reuteri
The results of the growth inhibition assays are
summarized in Table 1. Both L. reuteri strains
were able to inhibit the growth of five of the tested
Candida strains but not the two C. krusei strains.
In general, L. reuteri DSM 17938 was significantly
better at inhibiting the growth of the Candida
strains than L. reuteri PTA 5289 was (p <0.001);
the latter showed no complete inhibition of any of
the Candida strains. No statistically significant dif-
ferences were found between the two L. reuteri
strains for C. krusei. High cell concentrations (109
cfu/mL) of L. reuteri displayed no superiority at
inhibiting the Candida strains compared with
lower cell concentrations of the bacteria (<107
cfu/mL) in the bottom agar layer. For C. tropicalis
CCUG 47037, an even weaker inhibition tendency
was observed at high L. reuteri DSM 17938 cell
concentrations compared with lower cell concentra-
tions, whereas C. glabrata CBS 863 was completely
inhibited at high L. reuteri DSM 17938 cell con-
centrations compared with slight inhibition at
lower concentrations.
Bacterial acid production measured by ph
Typical results of the pH microsensor measurements in
the agar overlay cultures of the lactobacilli and Candida
strains and control plates are shown in Figures 2 and 3.
Similar pHmicroprofiles appeared for both strains of the
lactobacilli incubated with the Candida; pH measured
through the dense colonies of the Candida species that
were not inhibited by the lactobacilli at the inhibition
assay (C. krusei CCUG 56126 and Candida tropicalis
CCUG 47037) was approximately pH 6.0 at the surface
of the colonies, remaining above pH 4.5 until a depth of
1,500 µm, and only slowly becoming more acidic
throughout the agar layers approaching approximately
pH 4.0 in the bottom agar layer. In contrast, the pH
measured through the almost completely inhibited colo-
nies of C. albicans CCUG 46390 and C. glabrata CCUG
63819 already reached a very acidic level of approxi-
mately pH 3.6 only a few 100 µm under the surface and
remained stable throughout the agar layers.
H2O2 production by the lactobacilli
Both L. reuteri DSM 17938 and L. reuteri PTA 5289
showed a positive reaction for H2O2 production by
displaying clear-blue haloes around incubated colonies
after around 1 h exposure to ambient air. A similar
Figure 1. Co-aggregation ratio (%) between Candida strains and the Lactobacillus reuteri strains after 4 h of incubation. Mean,
error bars indicate standard deviations.
*Statistically significant differences (p < 0.05) .L. reuteri DSM 17938: C. tropicalis DSM 7524 showed significantly higher co-
aggregation ability compared with C. krusei CCUG 56126, C. dubliniensis 41_3 ZZMK, C. parapsilosis 26 PBS, C. glabrata CBS 863,
and C. parapsilosis CCUG 56136. L. reuteri ATCC PTA 5289: C. tropicalis DSM 7524 showed significantly higher co-aggregation
ability compared with C. glabrata CBS 863 and C. parapsilosis CCUG 56136. C. krusei CCUG 56126 showed a significantly greater
ability to co-aggregate compared with C. parapsilosis CCUG 56136.
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colour change was observed for S. sanguinis and S.
mitis but not for S. salivarius, and the two L. reuteri
strains were therefore verified as H2O2 producers.
Discussion
To the authors’ knowledge, this is the first study to
demonstrate that probiotic lactobacilli can hamper
Table 1. Growth inhibition of six clinical isolates and six reference Candida strains by two strains of the probiotic Lactobacillus
reuteri at different cell concentrations.
L. reuteri ATCC PTA 5289 L. reuteri DSM 17938
CFU/mL
Candida strain 109 107–105 103 109 107–105 103
C. albicans CBS 562 NT 1 1 1 0 0 0
C. albicans CCUG 46390 1 1 1 0 0 0
C. dubliniensis 41_3 ZZMK 1 1 1 1 0 1
C. dubliniensis CCUG 48722 1 1 1 1 1 1
C. glabrata CBS 863 1 1 1 0 1 1
C. glabrata CCUG 63819 1 1 1 1 1 1
C. krusei RV 491 2 2 2 2 2 2
C. krusei CCUG 56126 2 2 2 2 2 2
C. parapsilosis 26 PBS 1 1 1 1 0 0
C. parapsilosis CCUG 56136 1 1 1 1 1 1
C. tropicalis DSM 7524 1 1 1 1 1 1
C. tropicalis CCUG 47037 2 1 1 2 1 1
Inhibition scores according to Simark-Mattsson et al. [23]: 0 = complete inhibition (no visible colonies); 1 = slight inhibition (at least one visible colony
but definitely smaller amounts than at the control plate); and 2 = no inhibition (colonies equal to those at the control plate).
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Figure 2. Microsensor measurement of pH at selected Candida
strains grown by the agar overlay technique with L. reuteri ATCC
PTA 5289 (103 cfu/mL) in the bottom agar layer. Zero on the
vertical axis represents the first reading when the sensors hit
either a Candida colony or the agar plates without Candida
colonies. For the Candida controls without lactobacilli, data are
only presented for C. krusei CCUG 56126.
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Figure 3. Microsensor measurement of pH at selected
Candida strains grown by the agar overlay technique with
L. reuteri DSM 17938 (103 cfu/mL) in the bottom agar layer.
Zero on the vertical axis represents the first reading when the
sensors hit either a Candida colony or the agar plates without
Candida colonies. For the Candida controls without lactoba-
cilli, data are only presented for C. krusei CCUG 56126.
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the growth of a selection of the most commonly
isolated Candida species in the oral cavity under in
vitro conditions. It was found that both L. reuteri
strains were able to co-aggregate with the yeasts,
displaying the highest co-aggregation ratios with C.
tropicalis and C. krusei. Unfortunately, these two
Candida species seemed less susceptible to the sub-
stances produced by the lactobacilli, as their growth
was only slightly inhibited in the agar overlay inhibi-
tion assay. In an in vitro study by Verdenelli et al.
[20], L. plantarum 319 displayed the highest degree of
co-aggregation with C. glabrata and C. albicans
among five Lactobacillus strains tested. As is the
case for many probiotic properties of lactobacilli,
co-aggregation also appears to be strain specific and
is unique for each Lactobacillus strain involved. This
was confirmed in this study, since L. reuteri ATCC
PTA 5289 generally showed the highest co-aggrega-
tion capacity with all the Candida strains, and inter-
estingly, this probiotic strain originates from the oral
cavity. Co-aggregation is a recognized feature of the
early biofilm formation and involves adhesion recep-
tor interactions between complementary molecules
on the microbial cell surfaces [27]. As such, probiotic
competition with pathogenic Candida strains for
binding sites in the oral biofilms may partly explain
the beneficial outcome of previous clinical
trials [5,11].
The agar overlay interference test is a well-pro-
ven and relatively simple technique for exploring
the inhibition capabilities of probiotic bacteria
against oral pathogens [14,18,23]. Moreover, the
technique allows assessment of multiple Candida
strains on a single plate and with different cell
concentrations of the lactobacilli in the bottom
agar layer. In this study, both L. reuteri strains
were able to inhibit the growth of most of the
Candida strains, except for C. krusei and to some
extent C. tropicalis. This confirms the findings of
other in vitro studies that investigated the antifun-
gal effect of lactobacilli on Candida using varying
techniques [16,19–21]. Jiang et al. [28] found that
the most susceptible yeast to lactobacilli was C.
albicans, whereas C. krusei was unaffected under
all experimental conditions. Likewise, Zhao et al.
[29] failed to inhibit C. krusei in a disc diffusion
model. In this study, L. reuteri DSM 17938 demon-
strated stronger inhibition ability than L. reuteri
ATCC PTA 5289 did. The pH was measured
through the agar layers after 48 h of incubation of
the lactobacilli, and both L. reuteri strains were
equally good at producing organic acids, resulting
in a pH close to 3.6 in the agar. Hence, superior
interference of L. reuteri DSM 17938 must likely be
explained by other factors, such as an enhanced
H2O2 or reuterin production which has been sug-
gested in other studies [10,16,30].
It is likely that the observed inhibition of the yeasts
is caused by the acidic environment in the agar due to
lactic acid and other organic acids produced by the
two L. reuteri strains, either directly or due to the
production of bacteriocins at low pH [31]. Neutral-
to-alkaline extracellular pH is considered an optimal
pH for the growth of Candida species, since it
induces hyphal morphogenesis in C. albicans [32],
while at low pH, the fungus remains in the less
virulent budding yeast form [33]. In this study, a
very acidic environment was found in the agar only
a few 100 µm under the surface of the almost com-
pletely inhibited colonies of C. albicans and C. glab-
rata. The un-dissociated form of lactic acid has been
shown to pass the plasma membrane of yeast cells,
leading to an increased activity of an energy-consum-
ing plasma membrane H+-ATPase that removes pro-
tons from the intracellular environment. The
increased H+-ATPase activity exhausts the available
energy for growth and metabolism, leading to growth
inhibition and finally cell death [31,34]. Moreover, in
this study, a completely different result was observed
for the non-inhibited C. krusei and to some extent C.
tropicalis. Somehow, these fungi had neutralized the
acids, creating a pH of almost 6.0 at the surface and
only slowly decreasing down through the agar. This
indicates that these fungi inhibit the acidification
caused by the lactobacilli to ensure their survival. In
experimental studies, Halm et al. [31] found C. krusei
to be much more tolerant to lactic acid at low pH
than Saccharomyces cerevisiae, since lactic acid only
induced a weak short-term response in the intracel-
lular pH of C. krusei. It is possible that C. krusei (i)
actively produces extracellular ammonia (NH3) which
will increase the surrounding pH [32,35], (ii) has less
permeable plasma membranes to lactic acid, (iii) has
a higher buffer capacity inside the cells, or (iv) has a
higher H+-ATPase capacity than the other Candida
species tested in this study [31]. A combination of the
abovementioned factors may also occur.
Acid production by the lactobacilli may be a con-
cern in regard to the development of new caries
lesions in the oral cavity. Lactobacilli and strepto-
cocci, especially S. mutans, are abundant acidogenic
species in caries lesions in the oral cavity [36]. Yet, L.
reuteri strains have been shown to reduce the number
of S. mutans in clinical trials after a continuous reg-
ular intake due to its production of substances with
potent inhibitory activity on a wide range of bacterial
species [37]. However, the species cannot colonize the
oral cavity after ended intake and is therefore not
considered a threat to the development of new car-
ious lesions [38].
The strong oxidant H2O2 is a potent growth inhi-
bitor and is mainly produced by oxidases in the
carbon and energy metabolism of micro-organisms.
The present study was able to verify the H2O2
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production of both L. reuteri strains. However, the
method used was more qualitative than quantitative
and did not allow the amount of H2O2 produced by
the two strains to be determined. Candida species
have developed mechanisms to detoxify reactive oxy-
gen species (ROS), such as H2O2, in order to survive
and evade the host immune system [39]. Ramírez-
Quijas et al. [39] found that C. albicans was more
susceptible to H2O2 compared with C. glabrata, C.
parapsilosis, and especially C. krusei which was the
most resistant of the four species. There is a good
possibility that the non-albicans Candida species pos-
sess mechanisms other than those possessed by C.
albicans to detoxify ROS. Accordingly, it has been
proposed that the resistance of C. krusei and C. para-
psilosis to H2O2 is due to the presence of an oxidase
which is part of an alternative oxidative pathway [40].
It is important to stress that in vitro studies always
have limitations, since they can never mimic the
complex microbiota found in the oral cavity. In gen-
eral, the effects of probiotic bacteria are highly strain
specific, which was confirmed in this study. Even at
strain level, significant differences in co-aggregation
and growth inhibition abilities were found between
the two L. reuteri strains. This indicates that probio-
tics as such cannot just be put in one barrel and that
further in vitro and, more importantly, in vivo inves-
tigations are needed to increase the understanding on
the role of probiotic supplements in the prevention
and management of Candida infections in the oral
cavity.
Conclusions
The two probiotic L. reuteri strains exhibited anti-
fungal properties against five of the six most com-
mon Candida species in the oral cavity. The findings
clearly showed that some Candida species, particu-
larly C. krusei, were not affected by the probiotic
interference. The probiotic properties differed sig-
nificantly between the two Lactobacillus strains.
Thus, the understanding that the impact of probiotic
supplements is strain and host specific was
reconfirmed.
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